← Back to Clinical Trials
Recruiting NCT07437833

NCT07437833 Psychophysiological Responses to Six Single-Session Self-Regulation Interventions in a Female Adult With ADHD and Stabilized Bipolar Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07437833
Status Recruiting
Phase
Sponsor Poznan University of Physical Education
Condition ADHD - Attention Deficit Disorder With Hyperactivity
Study Type INTERVENTIONAL
Enrollment 1 participants
Start Date 2026-07-31
Primary Completion 2026-10-30

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Moderate-Intensity Aerobic Exercise on CycloergometerCyclic SighingAromatherapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1 participants in total. It began in 2026-07-31 with a primary completion date of 2026-10-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to explore how six short, 15-minute self-regulation techniques affect the body and brain in a female adult with ADHD and stabilized bipolar disorder. The techniques being tested include: * Aerobic exercise * Controlled breathing (cyclic sighing) * Aromatherapy with lavender essential oil * Listening to specific music (Solfeggio 528 Hz) * Virtual reality relaxation with forest imagery * Emotional Freedom Technique (EFT) tapping One session of quiet sitting with eyes open serves as a comparison. The participant will attend one 15-minute session per week for each technique. Before and after each session, the researchers will measure: * Heart rate and heart rate variability * Stress levels using Subjective Units of Distress Scale * Mood using a questionnaire * Blood pressure * Brain activity using EEG * Memory performance with a simple test (N-back) * Pain sensitivity The goal is to understand how these short, non-invasive techniques influence both physiological and psychological responses. Sessions are safe, short, and designed to involve minimal risk. The findings may help guide future research on relaxation and exercise strategies for people with ADHD and bipolar disorder.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of ADHD and bipolar disorder (type I or II) in stable remission. * No active depressive, manic, or psychotic episodes for at least 2 years. * No use of psychotropic medications, including mood stabilizers, antidepressants, antipsychotics, or ADHD medications, for at least 2 years. * No chronic somatic diseases (including neurological, cardiovascular, or metabolic disorders). * Regular sleep-wake rhythm during the week preceding the study. * Non-smoker. * No night-shift work in the week preceding the study. Exclusion Criteria: * Acute medical conditions that could affect study procedures. * Use of medications in the past 3 months that influence cardiovascular or neurological parameters. * Consumption of alcohol or psychoactive substances on the day before or day of the study. * Intense physical activity on the day before or day of the study. * Contraindications to moderate-intensity exercise on a cycle ergometer (e.g., recent injuries, chronic musculoskeletal conditions). * Contraindications to EEG measurement (e.g., scalp skin conditions preventing proper electrode placement, hypersensitivity to conductive gels or pastes).

Contact & Investigator

Central Contact

Beata Jóźwiak

✉ b.jozwiak@awf.poznan.pl

📞 (61) 835 53 49

Principal Investigator

Ida Laudańska-Krzemińska

STUDY DIRECTOR

Poznan University of Physical Education

Frequently Asked Questions

Who can join the NCT07437833 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying ADHD - Attention Deficit Disorder With Hyperactivity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07437833 currently recruiting?

Yes, NCT07437833 is actively recruiting participants. Contact the research team at b.jozwiak@awf.poznan.pl for enrollment information.

Where is the NCT07437833 trial being conducted?

This trial is being conducted at Poznan, Poland.

Who is sponsoring the NCT07437833 clinical trial?

NCT07437833 is sponsored by Poznan University of Physical Education. The principal investigator is Ida Laudańska-Krzemińska at Poznan University of Physical Education. The trial plans to enroll 1 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology